PEAR THERAPEUTICS

pear-therapeutics-logo

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

#People #Financial #Website #More

PEAR THERAPEUTICS

Social Links:

Industry:
Biotechnology MHealth Pharmaceutical Software Therapeutics

Founded:
2013-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.peartherapeutics.com

Total Employee:
101+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
409 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Nginx



Current Advisors List

elena-viboch_image

Elena Viboch Board Member @ Pear Therapeutics
Board_member
2020-12-01

nancy-schlichting_image

Nancy Schlichting Board Member @ Pear Therapeutics
Board_member
2020-12-01

kirthiga-reddy_image

Kirthiga Reddy Board Observer @ Pear Therapeutics
Board_member

thomas-shehab_image

Thomas Shehab Board Observer @ Pear Therapeutics
Board_observer
2016-01-01

not_available_image

Atticus Bieff Investor @ Pear Therapeutics
Board_member
2020-12-01

jamil-beg_image

Jamil Beg Board Observer @ Pear Therapeutics
Board_observer
2017-05-01

jeremy-sohn_image

Jeremy Sohn Board Observer @ Pear Therapeutics
Board_observer
2016-03-01

eric-leuthart_image

Eric Leuthart Advisory Board @ Pear Therapeutics
Advisor
2014-05-01

Current Employees Featured

corey-mccann_image

Corey McCann
Corey McCann President and Chief Executive Officer @ Pear Therapeutics
President and Chief Executive Officer
2014-01-01

stephen-smith_image

Stephen Smith
Stephen Smith Co-Founder @ Pear Therapeutics
Co-Founder
2014-01-01

patrick-kennedy_image

Patrick Kennedy
Patrick Kennedy Head of Advisory Board @ Pear Therapeutics
Head of Advisory Board

walter-greenleaf_image

Walter Greenleaf
Walter Greenleaf Chief Science Officer @ Pear Therapeutics
Chief Science Officer
2014-04-01

michael-jay-walker_image

Michael Jay Walker
Michael Jay Walker Software Engineer @ Pear Therapeutics
Software Engineer
2019-04-01

kathy-jeffery_image

Kathy Jeffery
Kathy Jeffery Chief People Officer @ Pear Therapeutics
Chief People Officer
2019-06-01

alex-waldron_image

Alex Waldron
Alex Waldron Chief Strategy Officer @ Pear Therapeutics
Chief Strategy Officer
2019-04-01

everett-crosland_image

Everett Crosland
Everett Crosland VP of Market Access, Reimbursement & Government Affairs @ Pear Therapeutics
VP of Market Access, Reimbursement & Government Affairs
2017-01-01

chris-guiffre_image

Chris Guiffre
Chris Guiffre CFO & COO @ Pear Therapeutics
CFO & COO
2017-12-01

julia-strandberg_image

Julia Strandberg
Julia Strandberg Chief Commercial Officer @ Pear Therapeutics
Chief Commercial Officer
2019-07-01

Founder


corey-mccann_image

Corey McCann

stephen-smith_image

Stephen Smith

walter-greenleaf_image

Walter Greenleaf

william-greene_image

William Greene

Stock Details


Company's stock symbol is NASDAQ:PEAR

Investors List

trustbridge-partners_image

Trustbridge Partners

Trustbridge Partners investment in Post-IPO Equity - Pear Therapeutics

pritzker-vlock-family-office_image

Pritzker/Vlock Family Office

Pritzker/Vlock Family Office investment in Post-IPO Equity - Pear Therapeutics

health-innovation-capital_image

Health Innovation Capital

Health Innovation Capital investment in Post-IPO Equity - Pear Therapeutics

the-eleven-fund_image

The Eleven Fund

The Eleven Fund investment in Post-IPO Equity - Pear Therapeutics

sarissa-capital-management_image

Sarissa Capital Management

Sarissa Capital Management investment in Post-IPO Equity - Pear Therapeutics

drx-capital_image

dRx Capital

dRx Capital investment in Post-IPO Equity - Pear Therapeutics

arboretum-ventures_image

Arboretum Ventures

Arboretum Ventures investment in Post-IPO Equity - Pear Therapeutics

jazz-venture-partners_image

Jazz Venture Partners

Jazz Venture Partners investment in Post-IPO Equity - Pear Therapeutics

pilot-house-ventures_image

Pilot House Ventures

Pilot House Ventures investment in Post-IPO Equity - Pear Therapeutics

palantir-capital_image

Palantir Capital

Palantir Capital investment in Post-IPO Equity - Pear Therapeutics

Official Site Inspections

http://www.peartherapeutics.com Semrush global rank: 1.47 M Semrush visits lastest month: 18.67 K

  • Host name: 2.217.239.35.bc.googleusercontent.com
  • IP address: 35.239.217.2
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Pear Therapeutics"

AstraZeneca Completes Acquisition Of Pearl Therapeutics

Jun 28, 2013 For more information, please visit: www.pearltherapeutics.com AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, โ€ฆSee details»

Pearl Therapeutics Company Profile 2024: Valuation, Investors ...

Information on acquisition, funding, cap tables, investors, and executives for Pearl Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Pear Therapeutics - Org Chart, Teams, Culture & Jobs | The Org

View Pear Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Pearl Therapeutics Inc - Company Profile and News

Company profile page for Pearl Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Pearl Therapeutics - VentureRadar

Pearl Therapeutics is a privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, including chronic obstructive pulmonary โ€ฆSee details»

Pear Therapeutics to Become a Public Company and Expand its โ€ฆ

Jun 22, 2021 Pear Therapeutics to Become a Public Company and Expand its Leadership Position in Prescription Digital Therapeutics Pear Therapeutics, Inc. (โ€œPearโ€) has built the first โ€ฆSee details»

Pear Therapeutics - Crunchbase Company Profile & Funding

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.See details»

Pear Therapeutics goes public on Nasdaq as Pear

BOSTON โ€“ December 3, 2021 โ€“ Pear Therapeutics, Inc. (โ€œPear Therapeuticsโ€), the leader in developing and commercializing software-based medicines,See details»

Pear Therapeutics Looks For A Buyer As It Struggles To Get

Mar 17, 2023 The move underscores the main challenge facing companies developing software as medicine: getting insurers and government-sponsored health insurance programs to pay for it.See details»

Pear Therapeutics - PitchBook

Pear Therapeutics Inc is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDTs), โ€ฆSee details»

AstraZeneca to acquire Pearl Therapeutics to strengthen โ€ฆ

Monday, 10 June 2013 AstraZeneca announced today that it has entered into a definitive agreement to acquire Pearl Therapeutics, a privately held company based in Redwood City, โ€ฆSee details»

Pear Therapeutics Mission, Values, Culture & Jobs - tealhq.com

Pear Therapeutics is dedicated to revolutionizing healthcare by harnessing the power of digital therapeutics, with a focus on treating a wide range of conditions through innovative software โ€ฆSee details»

Pearl Therapeutics, Inc. | Insights

May 24, 2023 Latest on Pearl Therapeutics, Inc. Already A Biomedtracker Subscriber?You have access to the full company record through your subscription.See details»

Pear Therapeutics: The Rise and Fall of a Digital Therapeutics Pioneer

Apr 12, 2023 In this blog post, we'll explore the history of Pear Theraprutics, its milestones, and the reasons behind its unforeseen downfall.See details»

Pear Therapeutics | Company Overview & News - Forbes

Before any organization pursues a digital transformation, they must first build three macro transformation pillars: culture, talent and technology.See details»

Pearl Therapeutics receives TiE50 Award from Global โ€ฆ

Pearl Therapeutics receives TiE50 Award from Global Entrepreneurship Network REDWOOD CITY, CALIF., May 21, 2012 โ€“ Pearl Therapeutics Inc. has been named a TiE50 Winner. The โ€ฆSee details»

Pear Therapeutics - Crunchbase

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.See details»

Pear Therapeutics - Digital Therapeutics Alliance

Pear Therapeutics is the leader in FDA-cleared prescription digital therapeutics. The companyโ€™s approach is to integrate clinically-validated software applications with previously approved โ€ฆSee details»

Sandoz signs agreement with Pear Therapeutics to develop and ...

Holzkirchen, April 18, 2018 - Sandoz, a Novartis division, announced today that it has entered into a collaboration with Pear Therapeutics to commercialize and continued development of novel โ€ฆSee details»

linkstock.net © 2022. All rights reserved